Cargando…

Pharmaceutical freedom : why patients have a right to self medicate /

Jessica Flanigan defends patients' rights of self-medication on the grounds that same moral reasons against medical paternalism in clinical contexts are also reasons against paternalistic pharmaceutical policies, including prohibitive approval processes and prescription requirements.

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor principal: Flanigan, Jessica (Autor)
Formato: Electrónico eBook
Idioma:Inglés
Publicado: New York : Oxford University Press, [2017]
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000Ii 4500
001 EBSCO_ocn988169814
003 OCoLC
005 20231017213018.0
006 m o d
007 cr |n|||||||||
008 170529s2017 nyu ob 001 0 eng d
040 |a YDX  |b eng  |e rda  |e pn  |c YDX  |d N$T  |d EBLCP  |d OCLCF  |d UAB  |d UBY  |d FIE  |d OH1  |d OCL  |d U3W  |d BUF  |d STBDS  |d CEF  |d KSU  |d BRX  |d OTZ  |d WYU  |d OCLCQ  |d LVT  |d TKN  |d TSC  |d OCLCO  |d OCLCQ  |d OCLCA  |d OCLCQ  |d OCLCA  |d K6U  |d OCLCO  |d OCL  |d OCLCQ  |d SFB  |d OCLCQ  |d PSYSI  |d OCLCQ 
019 |a 992350560  |a 992731535 
020 |a 9780190684570  |q (electronic bk.) 
020 |a 0190684577  |q (electronic bk.) 
020 |a 9780190684556  |q (electronic bk.) 
020 |a 0190684550  |q (electronic bk.) 
020 |z 0190684542 
020 |z 9780190684549 
029 1 |a AU@  |b 000066153499 
029 1 |a AU@  |b 000071533872 
035 |a (OCoLC)988169814  |z (OCoLC)992350560  |z (OCoLC)992731535 
050 4 |a RA401.A1 
060 4 |a 2017 G-659 
060 4 |a WB 120 
072 7 |a POL  |x 027000  |2 bisacsh 
072 7 |a POL  |x 019000  |2 bisacsh 
082 0 4 |a 362.1782  |2 23 
049 |a UAMI 
100 1 |a Flanigan, Jessica,  |e author. 
245 1 0 |a Pharmaceutical freedom :  |b why patients have a right to self medicate /  |c Jessica Flanigan. 
264 1 |a New York :  |b Oxford University Press,  |c [2017] 
264 4 |c ©2017 
300 |a 1 online resource 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
504 |a Includes bibliographical references and index. 
588 0 |a Online resource, title from PDF title page (EBSCO, viewed June 27, 2017). 
505 0 |a Cover; Pharmaceutical Freedom; Copyright; Contents; Acknowledgments; Introduction; 1. A Defense of Self-​Medication; 1.1 Two Motivating Cases; 1.2 Patients Know Best; 1.3 Patient Expertise and Drug Choice; 1.4 Intimate Choices; 1.5 Anti-​paternalism and Freedom to Choose; 1.6 Patient Protection; 1.7 Ignorance and Fraud; 1.8 Self-​Medication and Unapproved Drugs; 1.9 Self-​Medication and Prescription Drugs; 1.10 Conclusion; 2. Paternalism and Public Health; 2.1 Prohibition and Protection; 2.2 Soft Paternalism and Drug Regulation; 2.3 Children and Incompetent Adults 
505 8 |a 2.4 Hard Paternalism and Drug Regulation2.5 The Health Effects of Approval Requirements; 2.6 The Health Effects of Prescription Policies; 2.7 The Regulatory Reversal Test; 2.8 Certification Versus Approval; 2.9 Conclusion; 3. Rethinking Prescription Requirements; 3.1 Deadly Drugs; 3.2 Recreational Drugs and Addiction; 3.3 Therapeutics; 3.4 Antibiotics; 3.5 The Case for OTC Enhancements; 3.6 Rethinking Non-​Medical Use; 3.7 Public Health and Preventive Medication; 3.8 Conclusion; 4. Responsibility and Regulation; 4.1 How Regulation Kills; 4.2 Necessity and the Need to Test 
505 8 |a 4.3 Non-​Ideal and Ideal Theory4.4 The Risks of an Approval System; 4.5 The Risks of a Certification System; 4.6 Conclusion; 5. The Politics of Self-​Medication; 5.1 Patient-​Driven Development; 5.2 Disobedience and Distribution; 5.3 Civil Disobedience; 5.4 Protest and Activism; 5.5 Democratic Authority and Self-​Medication; 5.6 Conclusion; 6. The Business of Medicine; 6.1 Single Standards for Industry; 6.2 Private Options and the Global Marketplace; 6.3 Drug Prices and Deregulation; 6.4 Lifesaving Innovation and Patents; 6.5 Patents and Prizes; 6.6 Patents and the Rights of Producers 
505 8 |a 6.7 Conclusion7. Medical Autonomy and Modern Healthcare; 7.1 Markets and Medical Autonomy; 7.2 Pharmaceutical Marketing; 7.3 Off-​Label Marketing; 7.4 Professional Ethics; 7.5 Torts and Product Liability; 7.6 Insurance and Social Costs; 7.7 Conclusion; 8. Conclusion; References; Index 
520 |a Jessica Flanigan defends patients' rights of self-medication on the grounds that same moral reasons against medical paternalism in clinical contexts are also reasons against paternalistic pharmaceutical policies, including prohibitive approval processes and prescription requirements. 
590 |a eBooks on EBSCOhost  |b EBSCO eBook Subscription Academic Collection - Worldwide 
650 0 |a Drug accessibility  |x Law and legislation. 
650 0 |a Pharmacy  |x Law and legislation. 
650 0 |a Medical laws and legislation. 
650 0 |a Self medication. 
650 1 2 |a Ethics, Clinical 
650 1 2 |a Self Medication 
650 2 2 |a Prescription Drugs 
650 2 2 |a Paternalism 
650 2 2 |a Drug Industry  |x ethics 
650 2 2 |a Patient Rights 
650 2 |a Self Administration 
650 6 |a Automédication. 
650 7 |a POLITICAL SCIENCE  |x Public Policy  |x Social Security.  |2 bisacsh 
650 7 |a POLITICAL SCIENCE  |x Public Policy  |x Social Services & Welfare.  |2 bisacsh 
650 7 |a Self medication.  |2 fast  |0 (OCoLC)fst01111464 
650 7 |a Drug accessibility  |x Law and legislation.  |2 fast  |0 (OCoLC)fst01941193 
650 7 |a Medical laws and legislation.  |2 fast  |0 (OCoLC)fst01014309 
650 7 |a Pharmacy  |x Law and legislation.  |2 fast  |0 (OCoLC)fst01060303 
776 0 8 |i Print version :  |z 9780190684549 
856 4 0 |u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1540220  |z Texto completo 
938 |a EBL - Ebook Library  |b EBLB  |n EBL4883895 
938 |a EBSCOhost  |b EBSC  |n 1540220 
938 |a Oxford University Press USA  |b OUPR  |n EDZ0001712094 
938 |a YBP Library Services  |b YANK  |n 14517672 
938 |a YBP Library Services  |b YANK  |n 14656511 
994 |a 92  |b IZTAP